News | March 09, 2022
Indian Pharma Market growth flat in Feb 2022
Price was the key driver for the period
Price was the key driver for the period
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
A total of 17 labs will be operational across the country by this month
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
The availability of advanced SLED dialysis for critical patients, Plasmapheresis, CRRT machines along with ICCU dialysis complete the centre in every way
This has further strengthened its manufacturing presence in the United States of America
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Clinical trial supply company strengthens its presence in the European Union
Subscribe To Our Newsletter & Stay Updated
